84.79
price up icon1.04%   0.87
after-market Handel nachbörslich: 84.60 -0.19 -0.22%
loading
Schlusskurs vom Vortag:
$83.92
Offen:
$83.275
24-Stunden-Volumen:
10.75M
Relative Volume:
0.89
Marktkapitalisierung:
$211.79B
Einnahmen:
$63.43B
Nettoeinkommen (Verlust:
$16.42B
KGV:
13.07
EPS:
6.4861
Netto-Cashflow:
$14.72B
1W Leistung:
-1.40%
1M Leistung:
+4.50%
6M Leistung:
+8.71%
1J Leistung:
-22.74%
1-Tages-Spanne:
Value
$83.16
$84.89
1-Wochen-Bereich:
Value
$83.16
$86.46
52-Wochen-Spanne:
Value
$73.31
$109.92

Merck Co Inc Stock (MRK) Company Profile

Name
Firmenname
Merck Co Inc
Name
Telefon
908-740-4000
Name
Adresse
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Name
Mitarbeiter
75,000
Name
Twitter
@Merck
Name
Nächster Verdiensttermin
2025-02-04
Name
Neueste SEC-Einreichungen
Name
MRK's Discussions on Twitter

Vergleichen Sie MRK mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - General icon
MRK
Merck Co Inc
84.79 209.61B 63.43B 16.42B 14.72B 6.4861
Drug Manufacturers - General icon
LLY
Lilly Eli Co
802.83 734.54B 53.26B 13.80B -50.20M 15.08
Drug Manufacturers - General icon
JNJ
Johnson Johnson
193.22 462.69B 92.15B 25.12B 18.18B 10.36
Drug Manufacturers - General icon
ABBV
Abbvie Inc
229.57 400.78B 58.33B 3.73B 18.24B 2.1013
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
131.43 253.15B 53.40B 13.68B 16.89B 6.8864

Merck Co Inc Stock (MRK) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-10-13 Fortgesetzt Citigroup Neutral
2025-09-17 Herabstufung Berenberg Buy → Hold
2025-05-14 Herabstufung Citigroup Buy → Neutral
2025-04-22 Eingeleitet Cantor Fitzgerald Neutral
2025-02-18 Herabstufung Deutsche Bank Buy → Hold
2025-02-10 Herabstufung TD Cowen Buy → Hold
2025-01-08 Herabstufung Truist Buy → Hold
2024-12-20 Herabstufung BMO Capital Markets Outperform → Market Perform
2024-12-10 Fortgesetzt BofA Securities Buy
2024-12-04 Hochstufung HSBC Securities Hold → Buy
2024-11-15 Eingeleitet Wolfe Research Peer Perform
2024-11-11 Herabstufung Daiwa Securities Buy → Neutral
2024-10-17 Eingeleitet Bernstein Mkt Perform
2024-03-11 Herabstufung Societe Generale Hold → Sell
2024-01-04 Hochstufung TD Cowen Market Perform → Outperform
2023-11-09 Eingeleitet Deutsche Bank Buy
2023-10-27 Hochstufung BMO Capital Markets Market Perform → Outperform
2023-10-20 Hochstufung UBS Neutral → Buy
2023-07-14 Eingeleitet HSBC Securities Hold
2023-04-13 Hochstufung Citigroup Neutral → Buy
2023-03-28 Herabstufung Societe Generale Buy → Hold
2023-03-13 Herabstufung Wells Fargo Overweight → Equal Weight
2023-03-06 Eingeleitet Jefferies Buy
2023-02-22 Hochstufung Wolfe Research Peer Perform → Outperform
2023-01-04 Hochstufung BofA Securities Neutral → Buy
2022-11-18 Eingeleitet Credit Suisse Outperform
2022-10-10 Hochstufung Guggenheim Neutral → Buy
2022-09-14 Hochstufung Berenberg Hold → Buy
2022-07-06 Hochstufung Daiwa Securities Neutral → Buy
2022-06-06 Fortgesetzt SVB Leerink Outperform
2022-04-06 Fortgesetzt Morgan Stanley Equal-Weight
2021-12-17 Eingeleitet Goldman Buy
2021-12-16 Eingeleitet Daiwa Securities Neutral
2021-12-13 Herabstufung UBS Buy → Neutral
2021-12-09 Eingeleitet Wells Fargo Overweight
2021-12-07 Herabstufung Guggenheim Buy → Neutral
2021-11-29 Herabstufung Citigroup Buy → Neutral
2021-11-19 Eingeleitet BMO Capital Markets Market Perform
2021-11-01 Hochstufung Argus Hold → Buy
2021-09-07 Herabstufung Morgan Stanley Overweight → Equal-Weight
2021-07-27 Fortgesetzt Truist Buy
2021-05-20 Herabstufung Argus Buy → Hold
2021-04-07 Fortgesetzt RBC Capital Mkts Sector Perform
2020-11-10 Fortgesetzt Bernstein Outperform
2020-09-29 Eingeleitet Berenberg Hold
2020-08-03 Hochstufung Goldman Neutral → Buy
2020-06-12 Herabstufung Wolfe Research Outperform → Peer Perform
2020-02-27 Eingeleitet Barclays Overweight
2020-01-07 Eingeleitet RBC Capital Mkts Sector Perform
2019-10-17 Fortgesetzt BofA/Merrill Neutral
2019-08-16 Eingeleitet SVB Leerink Outperform
2019-07-03 Eingeleitet Mizuho Buy
2019-05-28 Eingeleitet Goldman Neutral
2019-05-13 Hochstufung Atlantic Equities Neutral → Overweight
2018-10-16 Bestätigt Citigroup Buy
2018-10-09 Fortgesetzt Guggenheim Buy
2018-04-23 Hochstufung Goldman Neutral → Buy
2018-04-17 Hochstufung Morgan Stanley Equal-Weight → Overweight
2018-04-05 Hochstufung Barclays Equal Weight → Overweight
2018-03-12 Hochstufung Leerink Partners Mkt Perform → Outperform
2018-02-14 Bestätigt Leerink Partners Mkt Perform
2018-02-07 Bestätigt Morgan Stanley Equal-Weight
2018-01-16 Hochstufung SunTrust Hold → Buy
Alle ansehen

Merck Co Inc Aktie (MRK) Neueste Nachrichten

pulisher
Oct 17, 2025

Bank of America Securities Reduces PT on Merck & Co., Inc. (MRK), Keeps a Buy Rating - Insider Monkey

Oct 17, 2025
pulisher
Oct 17, 2025

Merck & Co., Inc. $MRK Shares Sold by Chevy Chase Trust Holdings LLC - MarketBeat

Oct 17, 2025
pulisher
Oct 17, 2025

Easterly Investment Partners LLC Increases Holdings in Merck & Co., Inc. $MRK - MarketBeat

Oct 17, 2025
pulisher
Oct 17, 2025

Arista Wealth Management LLC Makes New $861,000 Investment in Merck & Co., Inc. $MRK - MarketBeat

Oct 17, 2025
pulisher
Oct 17, 2025

Vectors Research Management LLC Has $217,000 Position in Merck & Co., Inc. $MRK - MarketBeat

Oct 17, 2025
pulisher
Oct 17, 2025

Merck & Co., Inc. $MRK Stock Position Increased by Applied Finance Capital Management LLC - MarketBeat

Oct 17, 2025
pulisher
Oct 17, 2025

Stratos Investment Management LLC Has $9.52 Million Stake in Merck & Co., Inc. $MRK - MarketBeat

Oct 17, 2025
pulisher
Oct 17, 2025

Nordea Investment Management AB Purchases 1,319,358 Shares of Merck & Co., Inc. $MRK - MarketBeat

Oct 17, 2025
pulisher
Oct 17, 2025

Praxis Investment Management Inc. Sells 3,340 Shares of Merck & Co., Inc. $MRK - MarketBeat

Oct 17, 2025
pulisher
Oct 17, 2025

WealthPlan Investment Management LLC Purchases Shares of 13,893 Merck & Co., Inc. $MRK - MarketBeat

Oct 17, 2025
pulisher
Oct 17, 2025

Ritholtz Wealth Management Sells 14,311 Shares of Merck & Co., Inc. $MRK - MarketBeat

Oct 17, 2025
pulisher
Oct 16, 2025

Merck & Co. Keeps Eyes On Two Late-Stage Drugs In Ophthalmology - insights.citeline.com

Oct 16, 2025
pulisher
Oct 16, 2025

UK Finance Minister Seeks More Pharma InvestmentAstraZeneca (NASDAQ:AZN), Merck & Co (NYSE:MRK) - Benzinga

Oct 16, 2025
pulisher
Oct 16, 2025

Merck's Keytruda Plus Chemo Regimen Shows Overall Survival Benefit In Recurrent Ovarian Cancer Patients - Benzinga

Oct 16, 2025
pulisher
Oct 16, 2025

Is Recursion Pharmaceuticals a Millionaire Maker? - The Motley Fool

Oct 16, 2025
pulisher
Oct 16, 2025

Is Trending Stock Merck & Co., Inc. (MRK) a Buy Now? - Yahoo Finance

Oct 16, 2025
pulisher
Oct 16, 2025

Merck & Co., Inc. $MRK Shares Acquired by Turtle Creek Wealth Advisors LLC - MarketBeat

Oct 16, 2025
pulisher
Oct 16, 2025

Merck: Earnings Outlook Steady, Keytruda Now Has Some Breathing Room - Seeking Alpha

Oct 16, 2025
pulisher
Oct 16, 2025

S Bank Fund Management Ltd Trims Position in Merck & Co., Inc. $MRK - MarketBeat

Oct 16, 2025
pulisher
Oct 16, 2025

Aware Super Pty Ltd as trustee of Aware Super Buys 156,788 Shares of Merck & Co., Inc. $MRK - MarketBeat

Oct 16, 2025
pulisher
Oct 16, 2025

Patten & Patten Inc. TN Lowers Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat

Oct 16, 2025
pulisher
Oct 16, 2025

New York State Teachers Retirement System Buys 3,612 Shares of Merck & Co., Inc. $MRK - MarketBeat

Oct 16, 2025
pulisher
Oct 16, 2025

Merck & Co., Inc. $MRK Shares Sold by Deroy & Devereaux Private Investment Counsel Inc. - MarketBeat

Oct 16, 2025
pulisher
Oct 16, 2025

Allspring Global Investments Holdings LLC Reduces Holdings in Merck & Co., Inc. $MRK - MarketBeat

Oct 16, 2025
pulisher
Oct 16, 2025

Citi Raises Price Target on Merck (MRK), Citing Strong Pipeline and Oncology Strength - Insider Monkey

Oct 16, 2025
pulisher
Oct 15, 2025

Merck: A Golden Buying Opportunity (NYSE:MRK) - Seeking Alpha

Oct 15, 2025
pulisher
Oct 15, 2025

Merck's New HIV Treatment Works As Well As Top Drug In Late Trials - Benzinga

Oct 15, 2025
pulisher
Oct 15, 2025

Merck Announces New Data from Phase 3 Trials Evaluating the Investigational, Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir (DOR/ISL) in Adults with Virologically Suppressed HIV-1 Infection - FinancialContent

Oct 15, 2025
pulisher
Oct 15, 2025

Generali Asset Management SPA SGR Raises Stake in Merck & Co., Inc. $MRK - MarketBeat

Oct 15, 2025
pulisher
Oct 15, 2025

AEGON ASSET MANAGEMENT UK Plc Acquires 91,199 Shares of Merck & Co., Inc. $MRK - MarketBeat

Oct 15, 2025
pulisher
Oct 15, 2025

Merck & Co., Inc. $MRK Position Trimmed by Sagespring Wealth Partners LLC - MarketBeat

Oct 15, 2025
pulisher
Oct 15, 2025

TD Asset Management Inc Sells 240,683 Shares of Merck & Co., Inc. $MRK - MarketBeat

Oct 15, 2025
pulisher
Oct 15, 2025

Envestnet Portfolio Solutions Inc. Trims Stock Position in Merck & Co., Inc. $MRK - MarketBeat

Oct 15, 2025
pulisher
Oct 14, 2025

Boston Trust Walden Corp Purchases 37,557 Shares of Merck & Co., Inc. $MRK - MarketBeat

Oct 14, 2025
pulisher
Oct 14, 2025

Courier Capital LLC Sells 8,424 Shares of Merck & Co., Inc. $MRK - MarketBeat

Oct 14, 2025
pulisher
Oct 14, 2025

Wilmington Savings Fund Society FSB Trims Position in Merck & Co., Inc. $MRK - MarketBeat

Oct 14, 2025
pulisher
Oct 14, 2025

Morningstar Investment Management LLC Acquires Shares of 10,924 Merck & Co., Inc. $MRK - MarketBeat

Oct 14, 2025
pulisher
Oct 14, 2025

Vest Financial LLC Buys 20,838 Shares of Merck & Co., Inc. $MRK - MarketBeat

Oct 14, 2025
pulisher
Oct 14, 2025

Atria Wealth Solutions Inc. Cuts Stock Position in Merck & Co., Inc. $MRK - MarketBeat

Oct 14, 2025
pulisher
Oct 14, 2025

Pzena Investment Management LLC Buys New Holdings in Merck & Co., Inc. $MRK - MarketBeat

Oct 14, 2025
pulisher
Oct 14, 2025

Merck & Co., Inc. $MRK Shares Purchased by MGO One Seven LLC - MarketBeat

Oct 14, 2025
pulisher
Oct 14, 2025

Merck & Co. Earnings Preview: What to Expect - MSN

Oct 14, 2025
pulisher
Oct 14, 2025

Merck & Co. Earnings Preview: What To Expect - Barchart.com

Oct 14, 2025
pulisher
Oct 13, 2025

Merck: An Undervalued Stock In An Expensive Market - Seeking Alpha

Oct 13, 2025
pulisher
Oct 13, 2025

Merck & Co., Inc. (NYSE:MRK) Coverage Initiated by Analysts at Citigroup - MarketBeat

Oct 13, 2025
pulisher
Oct 13, 2025

Almanack Investment Partners LLC. Boosts Stake in Merck & Co., Inc. $MRK - MarketBeat

Oct 13, 2025
pulisher
Oct 13, 2025

NorthRock Partners LLC Buys 6,614 Shares of Merck & Co., Inc. $MRK - MarketBeat

Oct 13, 2025
pulisher
Oct 13, 2025

Verdence Capital Advisors LLC Reduces Stock Position in Merck & Co., Inc. $MRK - MarketBeat

Oct 13, 2025
pulisher
Oct 13, 2025

Merck & Co., Inc. $MRK Shares Bought by MOKAN Wealth Management Inc. - MarketBeat

Oct 13, 2025
pulisher
Oct 13, 2025

Merck & Co., Inc. $MRK Shares Sold by Leith Wheeler Investment Counsel Ltd. - MarketBeat

Oct 13, 2025
pulisher
Oct 13, 2025

Sequoia Financial Advisors LLC Has $23.68 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat

Oct 13, 2025

Finanzdaten der Merck Co Inc-Aktie (MRK)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
drug_manufacturers_general NVO
$54.37
price down icon 3.07%
$298.81
price up icon 1.01%
$122.81
price up icon 4.21%
drug_manufacturers_general NVS
$131.43
price up icon 0.50%
drug_manufacturers_general PFE
$24.51
price up icon 1.16%
Kapitalisierung:     |  Volumen (24h):